http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View More Recent Stories
-
Schrödinger to Host Conference Call to Discuss Second Quarter 2021 Financial Results
-
Schrödinger Hosts First Annual Educator’s Day and Announces “Teaching with Schrödinger” Program
-
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Schrödinger to Present at Two Virtual Investor Conferences in July
-
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Schrödinger to Present at Two Investor Healthcare Conferences in June
-
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Schrödinger Reports First Quarter 2021 Financial Results and Provides Company Update
-
Schrödinger to Present at the Bank of America Securities 2021 Virtual Healthcare Conference
-
Schrödinger to Host Conference Call to Discuss First Quarter 2021 Financial Results
-
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Schrodinger (SDGR) Reports Preclinical Data on Novel, Selective CDC7 Inhibitors Presented at American Association for Cancer Research Annual Meeting
-
Schrödinger Reports Preclinical Data on Novel, Selective CDC7 Inhibitors Presented at American Association for Cancer Research Annual Meeting
-
Schrödinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery
-
Schrödinger to Host Webcast in Conjunction with Presentation of Preclinical Data for Its CDC7 Program at Virtual AACR Annual Meeting
-
Schrödinger to Participate in Credit Suisse 2021 Healthcare Innovators Series: The Intersection of Drug Discovery, Drug Development and Artificial Intelligence
-
Schrödinger Announces Preclinical Data for CDC7 Program to Be Presented at AACR Virtual Annual Meeting 2021
-
Schrödinger Reports Financial Results for the Fourth Quarter and Full Year 2020 and Provides Outlook for 2021
-
Schrödinger to Present at the H.C. Wainwright Global Life Sciences Conference
-
Schrödinger Expands Agreement with Google Cloud to Further Bolster Its Drug Discovery and Materials Science Initiatives
-
Cathie Wood's ARK Bought Buys ~$200M More Tesla (TSLA) Monday on Sell-Off
-
Schrödinger to Present at the SVB Leerink Partners 10th Annual Global Healthcare Conference
-
Schrödinger to Host Conference Call to Discuss Fourth Quarter and Year-End 2020 Financial Results
-
Schrödinger Presents Data from Its MALT1 Inhibitor Program at the American Society of Hematology (ASH) 2020 Annual Meeting
-
Schrodinger Inc. (SDGR) Announces Multi-Target Drug Discovery, Development, and Commercialization Collaboration with Bristol Myers Squibb (BMY)
-
Schrödinger Announces a Multi-Target Drug Discovery, Development, and Commercialization Collaboration with Bristol Myers Squibb
-
Schrödinger, Inc. Reports Third Quarter 2020 Financial Results and Business Update
-
Schrödinger, Inc. Reports Third Quarter 2020 Financial Results and Business Update
-
Schrödinger to Present at Upcoming Investor Conferences
-
Schrödinger to Present Data from Its MALT1 Inhibitor Program at the American Society of Hematology (ASH) 2020 Annual Meeting
-
Schrödinger to Host Third Quarter 2020 Financial Results Conference Call and Webcast
-
Schrödinger to Present at the Morgan Stanley 18th Annual Global Healthcare Conference
-
Schrödinger, Inc. Reports Second Quarter 2020 Financial Results and Business Updates

